Stock BLTE BELITE BIO, INC
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Belite Bio, Inc

Equities

BLTE

US07782B1044

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
37.27 USD +0.73% Intraday chart for Belite Bio, Inc +15.28% -18.54%
Mar. 22 Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan MT
Mar. 22 Belite Bio, Inc Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan CI

Evolution of the average Target Price on Belite Bio, Inc

Price target over the last 5 years

History of analyst recommendation changes

df023846dd287cb3beb.Em44YC6DiDxx8yD1r6bbspei6SyMr7o50_xlOl77gsU.YxdCVXfNx2w9wnLMzdOLis3VhFy02-l8q5JSCQuIyY9FLA05GLD_CRK9Qw~c34ce69b837e135f0b375061dd8e056a

Analyst Recommendations on Belite Bio, Inc

Maxim Starts Coverage on Belite Bio with Buy Rating, $60 Price Target MT
HC Wainwright Raises Price Target on Belite Bio to $59 From $55, Maintains Buy Rating MT
Cantor Fitzgerald Initiates Belite Bio at Overweight Rating With $43 Price Target MT
SVB Securities Starts Belite Bio at Outperform With $25 Price Target MT
HC Wainwright Adjusts Belite Bio's Price Target to $55 From $58, Keeps Buy Rating MT
HC Wainwright Initiates Coverage on Belite Bio With Buy Rating, $58 Price Target MT
Benchmark Capital Initiates Belite Bio at Buy with $57 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
37.27 USD
Average target price
56.5 USD
Spread / Average Target
+51.60%
High Price Target
60 USD
Spread / Highest target
+60.99%
Low Price Target
50 USD
Spread / Lowest Target
+34.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Belite Bio, Inc

Maxim
HC Wainwright
Cantor Fitzgerald
SVB Securities LLC
Benchmark Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BLTE Stock
  4. Consensus Belite Bio, Inc